The Critical Interaction: CBD and Cytochrome P450 Drug Metabolism

This podcast episode, hosted by Dr. Donnelly Snipes, delves into the crucial interaction between cannabidiol (CBD) and Cytochrome P450 (CYP450) enzymes. CYP450 enzymes, primarily located in the liver, are fundamental for breaking down and clearing numerous substances, including many medications, from the body. The core argument is that CBD acts as a potent inhibitor of these vital enzymes, preventing them from performing their metabolic function effectively. This inhibition can lead to a significant increase in the blood levels of co-administered drugs, potentially elevating them to toxic or even life-threatening concentrations.

The episode highlights a wide array of medications susceptible to this interaction, including common classes such as antidepressants, opioids, benzodiazepines, antibiotics, anti-cancer drugs, antihistamines (e.g., Benadryl, Zyrtec), anti-epileptic drugs, blood pressure medications, blood thinners (like Warfarin), cholesterol-lowering statins, corticosteroids (e.g., Prednisone), NSAIDs (e.g., Naproxen, Ibuprofen), erectile dysfunction medications, proton pump inhibitors, heart rhythm medications, immunosuppressants, and prostate medications. A key practical takeaway is that many drugs metabolized by CYP450 enzymes often carry a "grapefruit warning" on their labels, serving as an easy identifier for potential interactions with CBD.

Given these risks, Dr. Snipes strongly advises individuals taking any medications metabolized by CYP450 to seek medical supervision and potential dose adjustments before incorporating CBD into their regimen. It is emphasized that the assumption of safety for over-the-counter substances like CBD, especially when combined with prescription drugs, is dangerous and unfounded. The podcast also briefly touches upon the inverse scenario, where certain medications might decrease the availability or effectiveness of CBD itself.

The broader implications underscore the critical importance of informed decision-making in healthcare and the necessity for patients to be fully aware of potential drug-supplement interactions. The episode serves as a vital educational resource, stressing that even seemingly benign natural compounds can have profound pharmacological effects, necessitating professional medical guidance to ensure patient safety and prevent adverse outcomes from medication buildup or reduced efficacy.

cytochrome p450 enzymes are things that you have in your body which are responsible for breaking down many substances so your liver can clear them out of the body

cbd is one of the most potent cytochrome for p450 inhibitors

it keeps cytochrome p450 from doing its job with a lot of different medications and it can increase blood levels of those drugs that you're taking including antidepressants and opioids and benzodiazepines for example

people taking other drugs that are metabolized by cytochrome p450 should seek medical supervision and potential dose adjustments prior to taking cbd

this in certain cases can be life-threatening

it is important not to assume or take for granted that something that you can get over the counter like cbd is safe to take with other medications

the medications that are metabolized by cytochrome p450 often come with a grapefruit warning so that's the easiest way to identify what might interact with cbd

some of these can really build up to toxic levels

in other instances it may work the opposite where the medication keeps the cbd from doing what it needs to do

you can look in the notes on this video and there will be a link to this article that is on pubmed that will that has a table